Transcatheter aortic valve implantation 10 years after valve-in-valve transcatheter aortic valve implantation for failing aortic valve homograft root replacement.
Alison DuncanSaeed MirsadreeCesare QuartoSimon DaviesPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) is an established therapy for a degenerated surgical bioprosthesis. TAVI-in-TAVI following ViV-TAVI has not been previously performed. We report a high-risk patient presenting with severe left ventricular failure secondary to undiagnosed critical aortic stenosis due to degeneration of the implanted transcatheter heart valve more than a decade after initial ViV-TAVI for a failing stentless aortic valve homograft. Successful TAVI-in-TAVI reversed the clinical and echocardiographic changes of decompensated heart failure with no evidence of coronary obstruction.
Keyphrases
- transcatheter aortic valve implantation
- aortic valve
- aortic stenosis
- aortic valve replacement
- transcatheter aortic valve replacement
- left ventricular
- heart failure
- ejection fraction
- mitral valve
- case report
- atrial fibrillation
- early onset
- coronary artery disease
- hypertrophic cardiomyopathy
- pulmonary hypertension
- acute heart failure